Adherence to follow-up examination after positive fecal occult blood test results affects colorectal cancer mortality: A Korea population-based cohort study

The impact of adherence to follow-up examination after a fecal occult blood test (FOBT) remains ill-defined. To evaluate the impact of adherence to the follow-up examination on clinical outcomes in individuals with positive FOBT results. This was a retrospective cohort study involving Korean individ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Digestive and liver disease 2021-05, Vol.53 (5), p.631-638
Hauptverfasser: Kim, Yu Jin, Shim, Jeong-Im, Park, Eunjung, Kang, Minjoo, Kang, Sinhee, Lee, Jessie, Tchoe, Ha Jin, Kong, Kyeong Ae, Kim, Duk Hwan, Kim, Byung Chang, Choi, Kui Son, Moon, Chang Mo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The impact of adherence to follow-up examination after a fecal occult blood test (FOBT) remains ill-defined. To evaluate the impact of adherence to the follow-up examination on clinical outcomes in individuals with positive FOBT results. This was a retrospective cohort study involving Korean individuals aged 50 years or older who participated in the National Cancer Screening Program for CRC from 2009 to 2010. Individuals who underwent a confirmative examination within a year after positive FOBT results were included in compliant group, and those who did not were included in non-compliant group. The incidence and stage of CRC, and 5-year survival were compared between two groups. 5,914 were diagnosed with CRC in the compliant group and 2,973 in the non-compliant group. The proportion of advanced-stage CRC was significantly higher in the non-compliant group (localized CRC 44.6% vs. 36.7% and distant CRC 8.7% vs. 12.5%, p< 0.0001). The survival probability within 5 years was 71.0% in the non-compliant group and 85.9% in the compliant group (hazard ratio 1.70, 95% CI, 1.52–1.90, p< 0.001). Individuals who underwent follow-up examination 1 year or more after positive FOBT had a lower survival rate compared with that in those who underwent examination within 1 year.
ISSN:1590-8658
1878-3562
DOI:10.1016/j.dld.2021.02.007